{
    "clinical_study": {
        "@rank": "111009", 
        "arm_group": {
            "arm_group_label": "Imrecoxib", 
            "arm_group_type": "Experimental", 
            "description": "0.1g,BID,po"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the efficacy and safety of Imrecoxib in the\n      treatment of patients with knee osteoarthritis."
        }, 
        "brief_title": "A Phase 4 Study of Imrecoxib in Treatment of Knee Osteoarthritis", 
        "condition": "Knee Osteoarthritis", 
        "condition_browse": {
            "mesh_term": [
                "Osteoarthritis", 
                "Osteoarthritis, Knee"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aged form 18 years to 75 years old\n\n          -  Diagnosed with osteoarthritis of the knee according to the American College of\n             Rheumatology\n\n          -  Functional capacity class of \u2160-\u2162\n\n        Exclusion Criteria:\n\n          -  Unstable angina\n\n          -  History of myocardial infarction within the last 6 months\n\n          -  Stroke in the 6 months before screening\n\n          -  New York Heart Association class \u2162-\u2163 congestive heart-failure\n\n          -  Systolic blood pressure\uff1e180mmHg,and/or Diastolic blood pressure\uff1e100mmHg\n\n          -  Peptic ulcer\n\n          -  Known contraindications to non-steroidal anti-inflammatory drug\uff08NSAID\uff09\n\n          -  Received aspirin within 3 days of baseline visit\n\n          -  Aspirin dosage>150mg/d\n\n          -  Known to be Allergic to sulfa and COX-2 inhibitors\n\n          -  Pregnancy or lactation\n\n          -  Glutamic-oxaloacetic transaminase and/or glutamic-pyruvic transaminase\uff1e2 times upper\n             limit of normal\n\n          -  Blood urine nitrogen\uff1e1.5 times upper limit of normal"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "2400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01985165", 
            "org_study_id": "HRARXB00434"
        }, 
        "intervention": {
            "arm_group_label": "Imrecoxib", 
            "intervention_name": "Imrecoxib", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 7, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong"
                    }, 
                    "name": "The Second Affiliated Hospital of Sun Yat-Sen University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cangzhou", 
                        "country": "China", 
                        "state": "Hebei"
                    }, 
                    "name": "Cangzhou Central Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuhan", 
                        "country": "China", 
                        "state": "Hubei", 
                        "zip": "430030"
                    }, 
                    "name": "Tongji Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lianyungang", 
                        "country": "China", 
                        "state": "Jiangsu", 
                        "zip": "222002"
                    }, 
                    "name": "The First People's Hospital of Lianyungang"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nanjing", 
                        "country": "China", 
                        "state": "Jiangsu"
                    }, 
                    "name": "Nanjing Drum Tower Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shenyang", 
                        "country": "China", 
                        "state": "Liaoning", 
                        "zip": "110004"
                    }, 
                    "name": "Shengjing Hospital of China Medical University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jinan", 
                        "country": "China", 
                        "state": "Shandong", 
                        "zip": "250012"
                    }, 
                    "name": "Qilu Hospital of Shandong University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jinan", 
                        "country": "China", 
                        "state": "Shandong"
                    }, 
                    "name": "The Second Hospital of Shangdong University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jinan", 
                        "country": "China", 
                        "state": "Shandong", 
                        "zip": "250014"
                    }, 
                    "name": "Qianfoshan Hospital Affiliated to Shandong University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hangzhou", 
                        "country": "China", 
                        "state": "Zhejiang"
                    }, 
                    "name": "Zhejiang Provincial People's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taizhou", 
                        "country": "China", 
                        "state": "Zhejiang"
                    }, 
                    "name": "Taizhou Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100730"
                    }, 
                    "name": "Beijing Hospital of the Ministry of Health"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100029"
                    }, 
                    "name": "China-Japan Friendship Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Peking University Third Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100034"
                    }, 
                    "name": "Peking University First Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Peking Union Medical College Hospita"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100020"
                    }, 
                    "name": "BeijingChao-YangHospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chongqing", 
                        "country": "China", 
                        "zip": "400042"
                    }, 
                    "name": "Daping Hospital and the Research Institute of Surgery of the Third Military Medical University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tianjin", 
                        "country": "China"
                    }, 
                    "name": "Tianjin First Center Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Multicenter\uff0cOpen-label Phase \u2163 Trial of Imrecoxib in Treatment of Knee Osteoarthritis", 
        "overall_official": {
            "affiliation": "Peking Union Medical College Hospita", 
            "last_name": "Fengchun Zhang, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Change from baseline in Patient's Assessment of Arthritis Pain, according to Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)3.0", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Week 24"
            }, 
            {
                "measure": "Number of Participants with Adverse Events as a Measure of Safety and Tolerability", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline to week 24"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01985165"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Jiangsu HengRui Medicine Co., Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Jiangsu HengRui Medicine Co., Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}